Author | Jonathan E. Rosenberg, MD | OncLive

Author | Jonathan E. Rosenberg, MD

Articles

Dr. Rosenberg on the KEYNOTE-045 Trial in Advanced Urothelial Cancer

May 27, 2020

Video

Jonathan E. Rosenberg, MD, discusses the phase 3 KEYNOTE-045 trial in advanced urothelial cancer.

Dr. Rosenberg on Enfortumab Vedotin/Pembrolizumab in Urothelial Carcinoma

April 01, 2020

Video

Jonathan E. Rosenberg, MD, medical oncologist, chief, Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the updated results of the phase Ib/II EV-103 trial (NCT03288545) with enfortumab vedotin-ejfv (Padcev) and pembrolizumab (Keytruda) in patients with locally advanced or metastatic urothelial carcinoma.

Dr. Rosenberg Discusses Challenges in Metastatic Urothelial Carcinoma

November 20, 2018

Video

Jonathan E. Rosenberg, MD, medical oncologist, chief, Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses challenges in the treatment of patients with metastatic urothelial carcinoma.

Dr. Rosenberg on Dosing of Nivolumab Plus Ipilimumab in Bladder Cancer

October 20, 2018

Video

Jonathan E. Rosenberg, MD, medical oncologist, chief, Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses dosing for the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in patients with metastatic urothelial carcinoma at the 2018 ESMO Congress.

x